Evidence map›Paper›PMID 42168823›Full record

ArticleACS chemical neuroscience2026

Spontaneous Insertion of Aβ42 Dimers but Not Monomers into a Cholesterol-Rich Lipid Bilayer.

Rachit Pandey, Thomas Ruggiero, Brian Andrews, Brigita Urbanc

Abstract read
In one paragraph

Article in ACS chemical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rachit PandeyPhysics Department, Drexel University, 3141 Chestnut St, Philadelphia, Pennsylvania 19104, United States.
Thomas RuggieroPhysics Department, Drexel University, 3141 Chestnut St, Philadelphia, Pennsylvania 19104, United States.
Brian AndrewsPhysics Department, Drexel University, 3141 Chestnut St, Philadelphia, Pennsylvania 19104, United States.ORCID 0000-0003-4469-3147
Brigita UrbancPhysics Department, Drexel University, 3141 Chestnut St, Philadelphia, Pennsylvania 19104, United States.ORCID 0000-0001-9159-7698

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The leading Alzheimer's disease (AD) hypothesis posits that oligomers formed by amyloid β-protein (Aβ), in particular 42-residue-long Aβ42, interact with a cellular membrane, causing a cascade of events leading to neurodegeneration. The modes of Aβ42-lipid interactions are not well understood. Here, we use explicit-solvent all-atom molecular dynamics (MD) to demonstrate that Aβ42 monomers interact with lipids differently than Aβ42 dimers. In our simulations, lipids in the absence and presence of Aβ42 form a lipid bilayer with a cholesterol-rich domain, resembling a lipid raft. Whereas lipids stabilize the Aβ42 monomer structure, they partially destabilize Aβ42 dimers. Unlike monomers, which interact exclusively with solvent-exposed lipid tails on one side of a bilayer, dimers exhibit additional modes of interactions with lipids, including spontaneous insertion into the cholesterol-rich domain of a bilayer and carpeting, thereby disrupting the lipid bilayer structure. Our findings provide a mechanistic explanation for why Aβ42 monomers are nontoxic and reveal that Aβ42 oligomer-induced toxicity emerges already at the stage of Aβ42 dimer formation.

Indexed as

Amyloid beta-PeptidesCholesterolLipid BilayersPeptide FragmentsHumansMolecular Dynamics SimulationProtein MultimerizationAmyloid beta-Peptidesamyloid beta-protein (1-42)CholesterolLipid BilayersPeptide FragmentsAlzheimer’s diseaseAmyloid β-protein (Aβ)CholesterolLipid bilayerMolecular dynamics

Identifiers

PMID42168823
PMCPMC13329904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.